USD 7.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -25.32 Thousand | -30.88 Thousand | -27.84 Thousand | -27.16 Thousand | -26.14 Thousand | -26.28 Thousand |
Net Income | -28.42 Thousand | -36.98 Thousand | -26.04 Thousand | -28.96 Thousand | -26.74 Thousand | -29.68 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 3100.00 | - | -1800.00 | 1800.00 | 600.00 | 3400.00 |
Other non-cash items | - | 6100.00 | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 20.45 Thousand | 34.18 Thousand | 29.02 Thousand | 21.95 Thousand | 29.7 Thousand | 28.63 Thousand |
Debt repayment | -20.45 Thousand | -34.18 Thousand | -29.02 Thousand | -105.67 Thousand | -29.7 Thousand | -28.63 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 127.62 Thousand | - | - |
Other Financing Activities | - | - | - | 1.00 | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 3100.00 | - | -1800.00 | 1800.00 | 600.00 | 3400.00 |
Cash at beginning of period | 5168.00 | 1870.00 | 687.00 | 5900.00 | 2348.00 | - |
Cash at end of period | 292.00 | 5168.00 | 1870.00 | 687.00 | 5900.00 | 2348.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -4876.00 | 3298.00 | 1183.00 | -5213.00 | 3552.00 | 2348.00 |
Free Cash Flow | -25.32 Thousand | -30.88 Thousand | -27.84 Thousand | -27.16 Thousand | -26.14 Thousand | -26.28 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -5353.00 | -6425.00 | -28.42 Thousand | -9309.00 | -5079.00 | -36.98 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -5281.00 | 1300.00 | 3100.00 | 1000.00 | -800.00 | - |
Other non-cash items | - | - | - | - | - | 6100.00 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 17.45 Thousand | 5000.00 | 20.45 Thousand | 300.00 | 8725.00 | 34.18 Thousand |
Debt repayment | -17.45 Thousand | -5000.00 | -20.45 Thousand | -300.00 | -8725.00 | -34.18 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -5281.00 | 1300.00 | 3100.00 | 1000.00 | -800.00 | - |
Cash at beginning of period | 167.00 | 5.00 | 5168.00 | 8014.00 | 5168.00 | 1870.00 |
Cash at end of period | 6983.00 | 167.00 | 292.00 | 5.00 | 8014.00 | 5168.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 6816.00 | 162.00 | -4876.00 | -8009.00 | 2846.00 | 3298.00 |
Free Cash Flow | -10.63 Thousand | -5125.00 | -25.32 Thousand | -8309.00 | -5879.00 | -30.88 Thousand |
NATURAL
2453
ADF
IMUC
PSHG
HEAL